Alpha Tau Medical Ltd.
DRTS Nasdaq· Surgical & Medical Instruments & Apparatus
Last close · Oct 26, 2026
$12.89
KIRA · Stoqly’s AI analyst, in plain words
- Alpha Tau Medical Ltd. lost $42.6M in fiscal 2025.
- Free cash flow was −$32.8M in fiscal 2025, — of revenue.
Market cap
$1.0B
P/E
—
Revenue
—
Net income
−$42.6M
Free cash flow
−$32.8M
Operating margin
—
Alpha Tau Medical Ltd. in 30 seconds · fiscal 2025
Does it make a profit?
−$42.6M
No. It lost money last year.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Alpha Tau Medical Ltd. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 20-F · Mar 9, 2026
- Legal name
- Alpha Tau Medical Ltd.
- CIK
- 0001871321
Alpha Tau Medical Ltd. · DRTS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Net income | −$27.3M | −$33.8M | −$29.2M | −$31.8M | −$42.6M |
| Diluted EPS | −$0.67 | −$0.53 | −$0.42 | −$0.45 | −$0.53 |
| Cash | |||||
| Cash from operations | −$11.8M | −$23.9M | −$18.0M | −$19.8M | −$26.7M |
| Capital expenditure | $2.9M | $0.9M | $6.4M | $2.2M | $6.1M |
| Free cash flow | −$14.7M | −$24.8M | −$24.4M | −$22.0M | −$32.8M |
| Share count change | 0.6% | 56.7% | 9.2% | 0.8% | 15.2% |
| Debt and strength | |||||
| Cash and short-term investments | $31.3M | $105M | $81.8M | $59.6M | $73.1M |
| Shareholders' equity | −$34.8M | $106M | $84.5M | $62.7M | $77.1M |
| Current ratio | 7.4x | 24.5x | 12.1x | 7.4x | 7.5x |
| Interest coverage | — | — | −475.7x | −119.0x | −121.9x |
| Returns and quality | |||||
| Return on equity | — | −95.3% | −30.7% | −43.2% | −61.0% |
| Return on tangible equity | — | −32.0% | −34.5% | −50.7% | −55.3% |
| Altman Z'' | −3.5 | 9.1 | 2.9 | −1.4 | −1.5 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$1.6M
1 insider
Of sales under plans
77%
$1.2M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Alpha Tau Medical Ltd. · DRTS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $12.89 a share, the company is worth $1.0B.
Source: SEC EDGAR XBRL filings (CIK 0001871321). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.